DAVID RANDALL GROSSHANS

Concepts (452)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Proton Therapy
78
2024
1638
9.050
Why?
Craniospinal Irradiation
13
2022
133
2.480
Why?
Brain Neoplasms
37
2023
4993
2.290
Why?
Relative Biological Effectiveness
21
2024
226
2.120
Why?
Radiotherapy, Intensity-Modulated
20
2023
2168
1.930
Why?
Radiotherapy Planning, Computer-Assisted
28
2024
2452
1.770
Why?
Cranial Irradiation
12
2023
322
1.720
Why?
Medulloblastoma
13
2024
586
1.670
Why?
Cerebellar Neoplasms
14
2024
486
1.670
Why?
Protons
23
2024
483
1.640
Why?
Memantine
7
2023
50
1.350
Why?
Organs at Risk
12
2023
560
1.330
Why?
Chordoma
5
2022
170
1.240
Why?
Radiotherapy Dosage
37
2024
4003
1.230
Why?
Linear Energy Transfer
15
2024
105
1.190
Why?
Hippocampus
11
2022
976
1.150
Why?
Radiation Injuries
19
2022
1472
1.140
Why?
Glioma
9
2023
1988
1.110
Why?
Radiotherapy, Image-Guided
4
2024
338
1.080
Why?
Monte Carlo Method
15
2021
704
1.040
Why?
Chondrosarcoma
4
2017
213
1.030
Why?
Photons
12
2021
537
1.030
Why?
Cognition
13
2023
982
0.930
Why?
Skull Base Neoplasms
4
2018
339
0.930
Why?
Radiobiology
3
2018
56
0.870
Why?
Heavy Ion Radiotherapy
5
2022
28
0.810
Why?
Ependymoma
6
2023
269
0.810
Why?
Craniopharyngioma
3
2023
56
0.760
Why?
Cognition Disorders
6
2020
774
0.730
Why?
Phantoms, Imaging
5
2024
1330
0.720
Why?
Heart
3
2016
1214
0.700
Why?
Child
59
2024
30492
0.690
Why?
Pituitary Neoplasms
3
2023
218
0.670
Why?
Memory Disorders
2
2018
295
0.640
Why?
Glioblastoma
4
2023
1781
0.640
Why?
Lymphopenia
1
2021
211
0.630
Why?
Memory, Short-Term
1
2019
161
0.600
Why?
Child, Preschool
40
2024
16999
0.580
Why?
Receptors, N-Methyl-D-Aspartate
7
2018
269
0.580
Why?
Radiotherapy
6
2020
1860
0.580
Why?
Neurons
3
2018
2461
0.560
Why?
Prefrontal Cortex
1
2018
215
0.550
Why?
Radiotherapy, Conformal
4
2016
898
0.550
Why?
Humans
121
2024
271884
0.540
Why?
Skull Neoplasms
1
2016
68
0.540
Why?
Radiometry
11
2024
1017
0.530
Why?
Neutrons
1
2016
117
0.530
Why?
Carcinoma, Non-Small-Cell Lung
4
2021
5566
0.520
Why?
Neuronal Plasticity
1
2018
326
0.520
Why?
Elementary Particles
1
2015
24
0.510
Why?
Models, Biological
5
2020
3223
0.500
Why?
Neoplasms, Radiation-Induced
2
2021
404
0.490
Why?
Cochlea
3
2024
118
0.480
Why?
Re-Irradiation
3
2022
166
0.470
Why?
Neurosurgical Procedures
1
2019
634
0.460
Why?
Radiotherapy Setup Errors
1
2014
85
0.460
Why?
Cancer Survivors
5
2021
744
0.450
Why?
Intelligence
3
2019
134
0.450
Why?
Long-Term Potentiation
5
2018
180
0.440
Why?
Sarcoma, Ewing
3
2024
426
0.430
Why?
Neoplasms
10
2021
15915
0.430
Why?
DNA Damage
2
2024
1989
0.430
Why?
Lung Neoplasms
5
2021
12012
0.430
Why?
Spine
2
2013
311
0.430
Why?
Hearing Loss
3
2024
173
0.420
Why?
Fetus
1
2016
674
0.420
Why?
Adolescent
39
2024
32663
0.420
Why?
Male
60
2024
128957
0.390
Why?
Cognitive Dysfunction
3
2022
329
0.390
Why?
Dose-Response Relationship, Radiation
8
2024
751
0.390
Why?
Radiation Pneumonitis
1
2013
313
0.380
Why?
Positron-Emission Tomography
2
2024
2198
0.380
Why?
Cell Survival
6
2021
3074
0.370
Why?
Rhabdomyosarcoma, Alveolar
3
2021
64
0.370
Why?
Organ Sparing Treatments
4
2018
280
0.370
Why?
Age Factors
8
2024
5520
0.360
Why?
Head and Neck Neoplasms
8
2021
4137
0.350
Why?
Astrocytoma
1
2012
335
0.350
Why?
Female
57
2024
149143
0.340
Why?
Chemoradiotherapy
3
2024
2029
0.340
Why?
Insurance, Health, Reimbursement
2
2021
67
0.340
Why?
Rhabdomyosarcoma, Embryonal
2
2021
76
0.330
Why?
Brain
8
2023
4252
0.330
Why?
Thoracic Neoplasms
3
2018
349
0.320
Why?
Rhabdomyosarcoma
3
2019
343
0.320
Why?
Radiation Protection
2
2022
204
0.310
Why?
Meningeal Neoplasms
1
2012
473
0.310
Why?
Gamma Rays
2
2020
241
0.310
Why?
Brain Stem
3
2022
185
0.300
Why?
Lung
2
2016
3294
0.300
Why?
Insurance Coverage
2
2021
272
0.290
Why?
Linear Models
4
2017
1100
0.290
Why?
Prospective Studies
16
2024
13400
0.280
Why?
Rats
10
2021
6638
0.280
Why?
Algorithms
8
2020
3923
0.270
Why?
Adult
28
2024
81857
0.270
Why?
Scattering, Radiation
3
2018
334
0.270
Why?
Carcinoma, Small Cell
1
2008
427
0.250
Why?
Spinal Neoplasms
4
2021
666
0.250
Why?
Neuroblastoma
2
2022
703
0.250
Why?
Infant
19
2022
13931
0.250
Why?
Excitatory Amino Acid Antagonists
4
2018
164
0.250
Why?
Rats, Sprague-Dawley
5
2018
2255
0.240
Why?
Bone Neoplasms
3
2024
2668
0.230
Why?
Methylphenidate
2
2022
91
0.230
Why?
Intelligence Tests
3
2022
89
0.230
Why?
Follow-Up Studies
13
2024
15267
0.230
Why?
National Cancer Institute (U.S.)
3
2018
218
0.220
Why?
Neuroectodermal Tumors, Primitive
2
2022
102
0.220
Why?
Neoplasms, Second Primary
3
2021
1388
0.220
Why?
Survivors
4
2022
1025
0.220
Why?
Neoplasm Recurrence, Local
9
2022
10365
0.220
Why?
Combined Modality Therapy
10
2021
9044
0.210
Why?
Tyrosine
2
2003
510
0.210
Why?
Cosmic Radiation
1
2022
15
0.210
Why?
Cell Death
3
2020
689
0.210
Why?
Retrospective Studies
22
2024
39780
0.210
Why?
Receptors, Glutamate
1
2002
25
0.210
Why?
Protein Kinase C
2
2002
419
0.210
Why?
Cisplatin
3
2024
2497
0.200
Why?
Prostatic Neoplasms
5
2021
5996
0.200
Why?
Astronauts
1
2022
58
0.200
Why?
Models, Statistical
2
2020
1190
0.200
Why?
Survivorship
1
2022
117
0.200
Why?
Insurance, Health
2
2021
263
0.200
Why?
Antigens, Surface
1
2002
311
0.190
Why?
Radiation Exposure
1
2022
74
0.190
Why?
Receptors, AMPA
1
2002
83
0.190
Why?
Quality of Life
7
2023
4749
0.190
Why?
Optic Nerve Glioma
1
2021
28
0.190
Why?
Treatment Outcome
13
2024
33863
0.190
Why?
Helium
2
2022
23
0.190
Why?
Electrons
2
2022
187
0.180
Why?
Young Adult
16
2024
22108
0.180
Why?
Scoliosis
1
2022
148
0.180
Why?
Space Flight
1
2022
129
0.180
Why?
Hypothyroidism
1
2022
211
0.180
Why?
Transcription Factor RelA
1
2020
185
0.180
Why?
X-Rays
1
2020
153
0.170
Why?
Hospitals, High-Volume
1
2020
77
0.170
Why?
Central Nervous System Neoplasms
2
2015
550
0.170
Why?
Xerostomia
1
2021
204
0.170
Why?
Time-to-Treatment
2
2018
312
0.170
Why?
Synapses
2
2018
556
0.170
Why?
Child Behavior Disorders
1
2019
76
0.170
Why?
Encephalitis
1
2020
153
0.170
Why?
Diffusion Tensor Imaging
1
2021
295
0.160
Why?
DNA End-Joining Repair
1
2019
92
0.160
Why?
Insurance Claim Review
1
2018
74
0.160
Why?
Abnormalities, Radiation-Induced
1
2018
6
0.160
Why?
Cancer Care Facilities
2
2020
908
0.160
Why?
Homologous Recombination
1
2019
187
0.160
Why?
Infratentorial Neoplasms
1
2018
48
0.150
Why?
Disease-Free Survival
8
2020
10259
0.150
Why?
Pituitary Gland
1
2018
157
0.150
Why?
Beta Particles
1
2017
9
0.150
Why?
Dendritic Spines
1
2018
58
0.150
Why?
Brain Stem Neoplasms
1
2019
102
0.150
Why?
Proportional Hazards Models
4
2023
5118
0.150
Why?
In Vitro Techniques
5
2007
1742
0.150
Why?
Alpha Particles
1
2017
26
0.150
Why?
Social Class
1
2019
322
0.150
Why?
Dementia
1
2022
482
0.150
Why?
Behavior, Animal
1
2020
754
0.140
Why?
Rhabdoid Tumor
2
2014
111
0.140
Why?
Longitudinal Studies
2
2019
2053
0.140
Why?
Genes, BRCA1
1
2019
398
0.140
Why?
Spinal Cord
3
2015
724
0.140
Why?
Activities of Daily Living
1
2019
559
0.140
Why?
Hypothalamus
1
2018
276
0.130
Why?
Executive Function
1
2017
149
0.130
Why?
Oxygen
1
2020
800
0.130
Why?
Radiosurgery
2
2018
1368
0.130
Why?
Middle Aged
14
2023
90395
0.130
Why?
Congresses as Topic
1
2017
296
0.130
Why?
Databases, Factual
2
2020
2287
0.130
Why?
Radiation Tolerance
4
2021
636
0.130
Why?
Teratoma
2
2014
253
0.130
Why?
Pelvic Neoplasms
2
2014
203
0.130
Why?
Aged
11
2023
73471
0.130
Why?
Attention
1
2017
286
0.130
Why?
Tumor Burden
5
2021
2035
0.130
Why?
Radiation Oncology
1
2020
558
0.130
Why?
Animals
15
2022
62807
0.130
Why?
Prognosis
7
2024
22537
0.120
Why?
Adaptation, Psychological
1
2019
787
0.120
Why?
Nootropic Agents
1
2014
32
0.120
Why?
Ethmoid Bone
1
2014
13
0.120
Why?
Developmental Disabilities
1
2019
689
0.120
Why?
Intracellular Signaling Peptides and Proteins
1
2020
1295
0.120
Why?
Health Services Accessibility
1
2021
809
0.120
Why?
Memory
1
2018
443
0.120
Why?
Disease Progression
5
2022
6909
0.120
Why?
Learning
1
2018
432
0.120
Why?
Computer Simulation
3
2015
1572
0.120
Why?
Axonal Transport
1
2014
40
0.120
Why?
Enzyme Activation
2
2012
1832
0.110
Why?
Anesthesia, Intravenous
1
2014
40
0.110
Why?
Carcinoma, Acinar Cell
1
2014
87
0.110
Why?
Feasibility Studies
3
2014
2349
0.110
Why?
Water
1
2016
383
0.110
Why?
Radiation Dosage
4
2020
1043
0.110
Why?
Parotid Neoplasms
1
2014
152
0.110
Why?
Protein Tyrosine Phosphatases
2
2012
193
0.110
Why?
Spinal Cord Neoplasms
1
2014
159
0.110
Why?
Cohort Studies
3
2019
9491
0.110
Why?
Antineoplastic Agents, Immunological
1
2022
1335
0.110
Why?
Neoplasm, Residual
1
2019
1741
0.110
Why?
Cell Line, Tumor
5
2024
14875
0.100
Why?
Lens, Crystalline
1
2013
163
0.100
Why?
Molecular Imaging
1
2014
187
0.100
Why?
Software
2
2019
1385
0.100
Why?
N-Methylaspartate
1
2012
54
0.100
Why?
Receptors, GABA-A
1
2012
83
0.100
Why?
Thyroid Gland
1
2014
369
0.100
Why?
Uncertainty
3
2019
327
0.100
Why?
Anesthesia
1
2015
306
0.100
Why?
Survival Rate
7
2020
12533
0.100
Why?
Incidence
3
2021
5861
0.100
Why?
Treatment Failure
3
2021
1432
0.100
Why?
Fractures, Compression
1
2012
42
0.100
Why?
Neoplasms, Germ Cell and Embryonal
1
2014
343
0.100
Why?
Cross-Linking Reagents
2
2002
167
0.100
Why?
Kaplan-Meier Estimate
5
2021
6270
0.100
Why?
Ear
1
2011
39
0.100
Why?
Electrophysiology
2
2002
364
0.100
Why?
Caspase 3
1
2012
481
0.090
Why?
Spinal Cord Injuries
1
2014
350
0.090
Why?
Neuropsychological Tests
3
2022
1175
0.090
Why?
Carbon
2
2022
164
0.090
Why?
Salivary Gland Neoplasms
1
2015
499
0.090
Why?
Biological Transport
1
2012
645
0.090
Why?
Desmoplastic Small Round Cell Tumor
1
2011
88
0.090
Why?
Kidney
2
2022
2265
0.090
Why?
Phosphorylation
3
2012
4984
0.090
Why?
Social Adjustment
2
2022
115
0.090
Why?
Verbal Learning
2
2022
87
0.090
Why?
Spinal Fractures
1
2012
140
0.090
Why?
Urinary Bladder Neoplasms
2
2021
2443
0.090
Why?
Risk Factors
7
2021
18045
0.090
Why?
Radiography
1
2014
1993
0.090
Why?
Aged, 80 and over
5
2018
31042
0.090
Why?
Abdominal Neoplasms
1
2011
249
0.080
Why?
Neutropenia
1
2013
1001
0.080
Why?
Synaptic Transmission
1
2012
476
0.080
Why?
Fatigue
3
2022
1280
0.080
Why?
Skin Diseases
1
2012
366
0.080
Why?
Time Factors
5
2021
13130
0.080
Why?
Electrocardiography
1
2014
1196
0.080
Why?
Heart Diseases
1
2014
739
0.080
Why?
Calcium-Binding Proteins
2
2020
557
0.070
Why?
Ifosfamide
1
2008
357
0.070
Why?
Image Processing, Computer-Assisted
1
2014
1707
0.070
Why?
Psychomotor Performance
1
2008
239
0.070
Why?
Pyramidal Cells
1
2007
171
0.070
Why?
Speech
1
2008
140
0.070
Why?
Antineoplastic Agents
5
2024
14653
0.070
Why?
Etoposide
1
2008
905
0.060
Why?
Audiometry, Pure-Tone
2
2018
31
0.060
Why?
Regression Analysis
2
2018
1588
0.060
Why?
Stem Cell Transplantation
1
2012
1423
0.060
Why?
Hearing
2
2018
64
0.060
Why?
Neoplasm Invasiveness
1
2012
4071
0.060
Why?
Nerve Net
1
2007
272
0.060
Why?
Cell Line
3
2021
5432
0.060
Why?
Apolipoprotein E4
1
2023
45
0.060
Why?
Pregnancy
1
2016
8100
0.050
Why?
Apolipoproteins E
1
2023
235
0.050
Why?
Moon
1
2022
13
0.050
Why?
Ions
1
2022
58
0.050
Why?
Pilot Projects
2
2022
2864
0.050
Why?
Chymotrypsin
1
2002
38
0.050
Why?
Cell Fractionation
1
2002
78
0.050
Why?
Cerebrospinal Fluid
1
2002
127
0.050
Why?
Neoplasm Grading
2
2019
1827
0.050
Why?
Tooth Abnormalities
1
2021
14
0.050
Why?
Infant, Newborn
3
2021
8602
0.050
Why?
Okadaic Acid
1
2001
32
0.050
Why?
Magnetic Resonance Imaging
4
2023
7929
0.050
Why?
Insurance Carriers
1
2021
12
0.050
Why?
Radiotherapy, Adjuvant
2
2018
2270
0.050
Why?
Survival Analysis
1
2012
9325
0.050
Why?
Graft vs Host Disease
1
2012
2804
0.050
Why?
Parotid Gland
1
2021
116
0.050
Why?
Excitatory Postsynaptic Potentials
1
2002
254
0.050
Why?
Physics
1
2021
44
0.050
Why?
Gliosis
1
2020
44
0.050
Why?
Ethanol
1
2003
269
0.050
Why?
Salivary Glands
1
2021
140
0.050
Why?
NF-KappaB Inhibitor alpha
1
2020
137
0.050
Why?
HMGB1 Protein
1
2020
40
0.050
Why?
Tetradecanoylphorbol Acetate
1
2001
252
0.050
Why?
Receptors, Tumor Necrosis Factor, Type I
1
2020
75
0.050
Why?
United States
4
2018
16050
0.050
Why?
Biology
1
2021
76
0.050
Why?
Heterozygote
1
2023
1057
0.050
Why?
Peptide Hydrolases
1
2002
264
0.040
Why?
Multivariate Analysis
1
2008
4352
0.040
Why?
Chloride Channels
1
2020
79
0.040
Why?
Glial Fibrillary Acidic Protein
1
2020
173
0.040
Why?
In Situ Nick-End Labeling
1
2020
449
0.040
Why?
Neurogenesis
1
2022
240
0.040
Why?
Cricetulus
1
2020
215
0.040
Why?
Molecular Dynamics Simulation
1
2020
140
0.040
Why?
Salvage Therapy
2
2021
2119
0.040
Why?
Proctitis
1
2019
19
0.040
Why?
Antiparkinson Agents
1
2020
69
0.040
Why?
Blotting, Western
2
2003
3646
0.040
Why?
Amino Acid Sequence
3
2001
4635
0.040
Why?
Cyclophosphamide
2
2021
3231
0.040
Why?
Bevacizumab
2
2014
957
0.040
Why?
Physical Phenomena
1
2018
19
0.040
Why?
Random Allocation
1
2020
746
0.040
Why?
Rad51 Recombinase
1
2019
125
0.040
Why?
Vision Disorders
1
2021
241
0.040
Why?
src-Family Kinases
1
2002
487
0.040
Why?
Ki-67 Antigen
1
2020
685
0.040
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2012
2903
0.040
Why?
Randomized Controlled Trials as Topic
2
2018
2679
0.040
Why?
Urinary Incontinence
1
2019
150
0.040
Why?
Practice Guidelines as Topic
2
2019
2429
0.040
Why?
Cell Membrane
1
2002
900
0.040
Why?
Florida
1
2018
115
0.040
Why?
Massachusetts
1
2018
144
0.040
Why?
Rats, Long-Evans
1
2018
111
0.040
Why?
Endocrine System Diseases
1
2018
91
0.040
Why?
Tumor Hypoxia
1
2017
24
0.040
Why?
Research Report
1
2019
144
0.040
Why?
Microfilament Proteins
1
2020
497
0.040
Why?
Income
1
2018
232
0.040
Why?
Lymphatic Irradiation
1
2018
139
0.040
Why?
Nephrectomy
1
2022
808
0.040
Why?
Antineoplastic Agents, Alkylating
1
2021
609
0.040
Why?
Drug Synergism
1
2001
1364
0.040
Why?
Multimodal Imaging
1
2021
553
0.040
Why?
DNA Breaks, Double-Stranded
1
2019
327
0.040
Why?
Enzyme Inhibitors
2
2003
1966
0.040
Why?
Margins of Excision
1
2018
314
0.030
Why?
Organ Size
1
2018
727
0.030
Why?
Gene Silencing
1
2019
832
0.030
Why?
Immunotherapy
2
2022
3545
0.030
Why?
Necrosis
1
2018
604
0.030
Why?
Visual Acuity
1
2021
861
0.030
Why?
Postoperative Complications
1
2012
5690
0.030
Why?
Isotopes
1
2016
36
0.030
Why?
Interdisciplinary Communication
1
2017
276
0.030
Why?
Adenocarcinoma
1
2014
7975
0.030
Why?
Tomography, X-Ray Computed
1
2012
7790
0.030
Why?
Genotype
1
2023
4265
0.030
Why?
Surgical Procedures, Operative
1
2018
358
0.030
Why?
Clinical Trials, Phase II as Topic
1
2018
686
0.030
Why?
Cystectomy
1
2019
632
0.030
Why?
Sample Size
1
2016
215
0.030
Why?
Tumor Necrosis Factor-alpha
1
2020
1613
0.030
Why?
Risk
1
2019
1950
0.030
Why?
Neuroimaging
1
2018
404
0.030
Why?
Mucositis
1
2015
150
0.030
Why?
Antineoplastic Combined Chemotherapy Protocols
3
2019
16610
0.030
Why?
Indans
1
2014
71
0.030
Why?
Sacrum
1
2015
139
0.030
Why?
Prostatectomy
1
2019
1006
0.030
Why?
Benzhydryl Compounds
1
2014
87
0.030
Why?
Thoracic Vertebrae
1
2015
201
0.030
Why?
Cervical Vertebrae
1
2015
220
0.030
Why?
Lumbar Vertebrae
1
2015
249
0.030
Why?
Fibroblasts
1
2020
1670
0.030
Why?
Aging
1
2002
1578
0.030
Why?
Troponin I
1
2014
131
0.030
Why?
Alternative Splicing
1
1997
613
0.030
Why?
BRCA1 Protein
1
1997
522
0.030
Why?
Medicare
1
2018
934
0.030
Why?
Drug Administration Schedule
1
2018
3539
0.030
Why?
Medical Records
1
2013
447
0.030
Why?
DNA
1
2020
3088
0.030
Why?
Natriuretic Peptide, Brain
1
2014
340
0.020
Why?
Histones
1
2019
1514
0.020
Why?
Erythema
1
2012
48
0.020
Why?
Esophagitis
1
2013
210
0.020
Why?
Antibodies, Monoclonal, Humanized
2
2014
3392
0.020
Why?
Socioeconomic Factors
1
2016
1262
0.020
Why?
Registries
1
2019
2250
0.020
Why?
Vomiting
1
2013
361
0.020
Why?
Deglutition Disorders
1
2015
488
0.020
Why?
Cross-Sectional Studies
1
2021
4507
0.020
Why?
Nausea
1
2013
540
0.020
Why?
Vinblastine
1
2011
462
0.020
Why?
Cerebral Arteries
1
2011
100
0.020
Why?
Interferons
1
2011
301
0.020
Why?
DNA Repair
1
2018
1912
0.020
Why?
Chemotherapy, Adjuvant
1
2018
3978
0.020
Why?
Erythrocyte Transfusion
1
2011
211
0.020
Why?
Referral and Consultation
1
2015
940
0.020
Why?
Cells, Cultured
1
2018
5787
0.020
Why?
Mice, Inbred BALB C
1
2014
2469
0.020
Why?
Radiation-Sensitizing Agents
1
2011
366
0.020
Why?
Mice, Inbred C57BL
1
2020
7232
0.020
Why?
Receptor, ErbB-2
1
1999
2649
0.020
Why?
Dacarbazine
1
2011
505
0.020
Why?
Recurrence
1
2018
4886
0.020
Why?
Mice
2
2020
36041
0.020
Why?
Piperidines
1
2014
1091
0.020
Why?
Camptothecin
1
2011
538
0.020
Why?
Weight Loss
1
2013
639
0.020
Why?
Lymphatic Metastasis
1
2018
4968
0.020
Why?
Cell Proliferation
1
2020
7300
0.020
Why?
Image Interpretation, Computer-Assisted
1
2012
592
0.020
Why?
2-Amino-5-phosphonovalerate
1
2007
27
0.020
Why?
Propionates
1
2007
79
0.020
Why?
Pain Measurement
1
2012
1016
0.020
Why?
Clinical Trials as Topic
1
2017
3853
0.020
Why?
Angiogenesis Inhibitors
1
2014
1265
0.020
Why?
Hyperthermia, Induced
1
2011
510
0.020
Why?
Texas
1
2018
6435
0.020
Why?
Lymph Nodes
1
2018
3080
0.020
Why?
Skin
1
2012
1284
0.020
Why?
Thrombocytopenia
1
2011
872
0.020
Why?
Apoptosis
1
2020
7837
0.020
Why?
Biphenyl Compounds
1
2007
192
0.020
Why?
Electric Stimulation
1
2007
492
0.020
Why?
Protein Transport
1
2007
739
0.020
Why?
Peritoneal Neoplasms
1
2011
856
0.020
Why?
Biopsy
1
2012
3544
0.010
Why?
Neoplasm Staging
1
2019
13993
0.010
Why?
Signal Transduction
1
2002
12222
0.010
Why?
Gene Expression Regulation, Neoplastic
1
1999
9099
0.010
Why?
Analysis of Variance
1
2007
2337
0.010
Why?
Surveys and Questionnaires
1
2015
5928
0.010
Why?
Precipitin Tests
1
2003
360
0.010
Why?
Rats, Inbred F344
1
2002
238
0.010
Why?
Pediatrics
1
2011
1184
0.010
Why?
Molecular Sequence Data
2
1999
6781
0.010
Why?
Dose-Response Relationship, Drug
1
2007
5104
0.010
Why?
Mutation
1
2019
15924
0.010
Why?
Blotting, Northern
1
1999
735
0.010
Why?
Gene Amplification
1
1999
770
0.010
Why?
COS Cells
1
1997
423
0.010
Why?
Gene Expression Regulation
1
2007
4199
0.010
Why?
Biomarkers, Tumor
1
2014
10750
0.010
Why?
Breast Neoplasms
1
1999
16241
0.010
Why?
Cytoplasm
1
1997
718
0.010
Why?
Liver Neoplasms
1
2011
4809
0.010
Why?
Cytomegalovirus
1
1997
493
0.010
Why?
Sequence Deletion
1
1997
915
0.010
Why?
Exons
1
1997
1388
0.010
Why?
Tumor Cells, Cultured
1
1999
5804
0.010
Why?
Transfection
1
1997
3165
0.010
Why?
Cell Nucleus
1
1997
1740
0.010
Why?
Genetic Vectors
1
1997
1885
0.010
Why?
Polymerase Chain Reaction
1
1997
3512
0.010
Why?
Base Sequence
1
1997
5499
0.010
Why?
Phenotype
1
1999
6515
0.000
Why?
Ovarian Neoplasms
1
1999
4795
0.000
Why?
GROSSHANS's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (452)
Explore
_
Co-Authors (148)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_